Apolipoprotein E gene and sporadic frontal lobe dementia

Neurology

Volumn 48, Issue 6, 1997, Pages 1526-1529

  Stevens, M ^b   Van Duijn, C M ^c   De Knijff, P ^c   Van Broeckhoven, C ^a   Heutink, P ^c   Oostra, B A ^c   Niermeijer, M F ^c   Van Swieten, J C ^c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC IMAGING; DISEASE DURATION; FEMALE; FRONTAL LOBE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; MALE; NETHERLANDS; NEUROPSYCHOLOGICAL TEST; ONSET AGE; POPULATION RESEARCH; PRESENILE DEMENTIA; PRIORITY JOURNAL;

EID: 0030767884     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.6.1526     Document Type: Article

References (31)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
3. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
4. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E, E4 allele as a major risk factor for sporadic early and late-onset form of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:569-574.
5. Van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 1994;7:74-78.
6. Tierney MC, Szalai JP, Snow WG, et al. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 1996; 46:149-154.
7. Shimano H, Murase T, Ishibashi S, et al. Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis 1989;79:257-260.
8. Frisoni GB, Geroldi C, Bianchetti A, et al. Apolipoprotein E ∈4 allele frequency in vascular dementia and Alzheimer's disease. Stroke 1994;25:1703-1704.
9. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E ∈4 association with dementia in a population-based study: the Framingham Study. Neurology 1996;46:673-677.
10. Kawamata J, Tanaka S, Shimohama S, et al. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 1994; 57:1414-1416.
11. Harrington CR, Louwagie J, Rossau R, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol 1994;145:1472-1484.
12. St Clair D, Norrman J, Perry R, Yates C, Wilcock G, Brookes A. Apolipoprotein E ∈4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett 1994;176:45-46.
13. Olichney JM, Hansen LA, Galasko D, et al. The apolipoprotein E ∈4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1997;(in press).
14. Pickering-Brown SM, Mann DMA, Bourke JP, et al. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other β-amyloid-forming diseases. Lancet 1994; 343:1155.
15. Arai H, Higuchi S, Muramatsu T, et al. Apolipoprotein E gene in diffuse Lewy body disease with or without co-existing Alzheimer's disease. Lancet 1994;344:1307.
16. Amouyel P, Vidal O, Launay JM, Laplanche JL. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet 1994;344:1315-1318.
17. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-711.
18. Neary D, Pickering-Brown S, Roberts D, Owen P. Apolipoprotein E4 alleles and non-Alzheimer's disease forms of dementia [letter]. Neurodegeneration 1993;2:300-301.
19. Pickering-Brown SM, Siddons M, Mann DMA, Owen F, Neary D, Snowden JS. Apolipoprotein E allelic frequencies in patients with lobar atrophy. Neurosci Lett 1995;188:205-207.
20. Schneider JA, Gearing M, Robbins RS, et al. Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann Neurol 1995;38:131-135.
21. Farrer LA, Abraham C, Volicer L, Kowall N, McKee A. Wells J. Dose effect of allele ∈4 of apolipoprotein E on risk and age at onset of Pick disease [abstract]. Am J Hum Genet 1994; 55(suppl):A48.
22. The Lund and Manchester Groups: clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
23. Hofman A, Grobbee DE, DeJong PTVM, Vandenouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-422.
24. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:185-198.
25. Reymer PWA, Groenemeyer BE, van de Burg R, Kastelein JJP. Apolipoprotein E genotyping on agarose gels. Clin Chem 1995;41:1046-1047.
26. Van Duijn CM, de knijff P, Wehnert A, et al. The apolipoprotein E ∈2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995;37:605-610.
27. Bresiow NE, Day NE. Statistical methods in cancer research. Volume II: the design and analysis of cohort studies. Lyon: International Agency for Research on Cancer, IARC, Scientific Publications No 82, 1987.
28. Van Gool WA, Evenhuis HM, Van Duijn CM, on behalf of the Dutch Study Group on Down's Syndrome and Ageing. A case-control study of apolipoprotein E genotypes in Alzheimer's disease with Down's syndrome. Ann Neurol 1995;38.225-230.
29. Al-Chalabi A, Enayat ZE, Bakker MC, et al. Association of apolipoprotein E ∈4 allele with bulbar-onset motor neuron disease. Lancet 1996;347:159-160.
30. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 1995;274:1627-1629.
31. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Akheimer's disease. Ann Neurol 1995;38:6-14.